Microsoft Unveils BioEmu AI for Drug Discovery

• Microsoft has introduced BioEmu, an AI system to accelerate drug discovery by understanding protein motion.
• BioEmu predicts protein shapes and movements crucial for disease understanding and drug design.
• It offers rapid insights, completing simulations in hours instead of years, saving time and cost.
• The AI can detect hidden protein structures, aiding in targeted drug development.
• Published in Science, BioEmu is a generative deep learning model with significant potential in various scientific fields.

Source: Mint